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Purpose or Objective 
Risk estimation of urinary toxicity after prostate 
radiotherapy is generally based on bladder DVH, 
disregarding any spatial dose-distribution information. 
The objectives of the study were: 
- To identify bladder subregions associated with urinary 
toxicity via pixel-wise and voxel-wise statistical analysis 
on 2D dose-surface maps (DSM) and 3D dose-volume maps 
(DVM), respectively.  
- To evaluate their prediction capabilities with respect to 
the DVH of the whole bladder. 
Material and Methods 
In total 272 prostate cancer patients treated with 
IMRT/IGRT from two multicentric phase III trials (STIC- 
IGRT and PROFIT), were prospectively analyzed. Local 
relationships between dose and specific urinary endpoints 
were investigated via 2D DSMs and 3D DVMs, by analyzing 
the planning dose distribution at pixel and voxel scales, 
respectively. DSMs were generated by anteriorly cutting 
and virtually unfolding the bladder surface. Maps were 
laterally normalized and aligned at the most inferior-
posterior point. Normalized DSMs (nDSM) both laterally 
and vertically were also computed. DVMs were produced 
by first non-rigidly registering the population to a common 
coordinate system and then propagating the 3D dose 
distribution according to the transformation beforehand 
obtained. Pixel and voxel–wise non parametric analyses 
were performed, for DSMs and DVMs respectively, to 
identify regions of statistically significant dose differences 
between patients with/without toxicities. The spatial 
correlation between the regions found with the nDSMs and 
DVMs for each symptom was evaluated with the Jaccard 
score (intersection surface divided by union surface). 
Prediction capability was estimated by the area under the 
ROC curve (AUC) from logistic regression, performed at 
each dose bin of the DVH of the sub-volumes, the dose-
surface histogram (DSH) of the sub-surfaces, and the DVH 
of the whole bladder. 
Results 
A local dose-effect relationship was found for three late 
toxicity endpoints: incontinence (grade≥2), retention 
(grade≥1) and dysuria (grade≥1). The 5-year toxicity rates 
were 4%, 23% and 13%, respectively. The subregions found 
with the two methods are mostly located in the inferior 
and posterior bladder. The Jaccard scores were 0.3 
(dysuria), 0.42 (retention) and 0.7 (incontinence). Figure 
1 shows the identified sub-surface (top) and sub-volume 
(bottom) for urinary incontinence. Table 1 shows the 
prediction capabilities, for each endpoint, of the sub-
volume’s DVH, sub-surface’s DSH and whole bladder’s 
DVH. The dose bin with the highest significant AUC is 
reported. 
Conclusion 
Specific bladder subregions were identified by the two 
methods as more predictive of urinary toxicity than the 
whole bladder. Particularly, the DVM method highlights 
the importance of volumes near the bladder surface, but 
inside bladder volume, underlining the influence of 
variable bladder filling and, thus, entailing the need of 
optimizing dose even in “non-obvious” regions (i.e. what 
appears to be urine at planning CT). 
